Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C1q complement component and -antibodies reflect SLE activity and kidney involvement.

P Horák1, Z Hermanová, J Zadrazil

  • 13rd Department of Internal Medicine, Faculty of Medicine, Palacký University of Olomouc, I. P. Pavlova 6, 772 00, Olomouc, Czech Republic. horakp@fnol.cz

Clinical Rheumatology
|November 29, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence of Spin-Interference Effects in Exclusive J/ψ→e^{+}e^{-} Photoproduction in Ultraperipheral Heavy-Ion Collisions.

Physical review letters·2026
Same author

First Experimental Limit on the Permanent Electric Dipole Moment of the Deuteron.

Physical review letters·2026
Same author

First Observation of Deuteron-Λ Correlations at RHIC.

Physical review letters·2026
Same author

Observation of the Radiative Decay D_{s0}^{*}(2317)^{+}→D_{s}^{*+}γ.

Physical review letters·2026
Same author

First Search for B→X_{s}νν[over ¯] Decays.

Physical review letters·2026
Same author

Search for Feebly Interacting Particles in B Decays with Missing Energy at Belle.

Physical review letters·2026

Anti-C1q antibodies and C1q levels in systemic lupus erythematosus (SLE) patients show a mirror-like pattern. Elevated anti-C1q antibodies and decreased C1q levels correlate with active disease and lupus nephritis.

Area of Science:

  • Immunology
  • Rheumatology
  • Systemic Autoimmune Diseases

Background:

  • The complement system plays a complex role in systemic diseases like systemic lupus erythematosus (SLE).
  • Abnormalities in complement activation are frequently observed in SLE patients.
  • Anti-C1q antibodies are significant autoantibodies associated with SLE pathogenesis.

Purpose of the Study:

  • To evaluate serum levels of anti-C1q antibodies and the C1q complement component in SLE patients.
  • To assess these markers in relation to lupus nephritis and disease activity (ECLAM).
  • To explore correlations between anti-C1q antibodies, C1q levels, and clinical/laboratory parameters.

Main Methods:

  • Serum samples from 65 SLE patients were analyzed.
  • Anti-C1q antibodies were quantified using Enzyme-Linked Immunosorbent Assay (ELISA).

Related Experiment Videos

  • C1q complement component levels were measured by radial immunodiffusion (Mancini method).

    • Main Results:

    • Significant differences in anti-C1q antibody levels were found between patients with and without lupus nephritis (p=0.0001) and between active and nonactive SLE (p=0.001).
    • C1q complement component levels were significantly lower in patients with lupus nephritis (p=0.002) and active SLE (p=0.001).
    • Anti-C1q antibodies and C1q levels exhibited an inverse relationship, suggesting a mirror-like pattern.

    Conclusions:

    • Anti-C1q antibodies and C1q levels serve as potential biomarkers for SLE activity.
    • These markers may indicate the presence and severity of lupus nephritis.
    • The inverse correlation suggests a dynamic interplay between C1q consumption and antibody formation in SLE.